About NEBA^®

NEBA is a biologically-based ADHD assessment aid for children and adolescents between the ages of 6 and 17. Clinicians use NEBA to detect neural activity using an EEG marker.

NEBA is quantitative and non-invasive and has been standardized for use as one part of a full psychiatric workup. Using NEBA is simple, quick, accurate, and reliable.

A clinician first makes an ADHD diagnosis and then uses the NEBA Report for confirmation or as support for further clinical testing.

NEBA is not a stand-alone diagnostic. The device is NOT to be used as a stand-alone in the evaluation or diagnosis of ADHD.

General NEBA Information (PDF)

Recent Events

Lexicor Medical Technology employee, Linda Stone earns Regulatory Affairs Certification (RAC)
January 6, 2011
More >

Qualifying Therapeutic Discovery grants cap year of successful NEBA^® milestones.
November 5, 2010
More >

NEBA^® receives Health Canada Medical Device License -- Key step for NEBA^®
September 16, 2010
More >

NEBA^® garners CE Mark -- EEG-based assessment aid specifically indicated for ADHD, key step for neuropsychiatric assessment aids.
July 07, 2010
More >

Lexicor Medical Technology Achieves ISO 13485 Certification March 29, 2010
More >